thalidomide has been researched along with spautin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bradner, J; Briggs, KJ; Buhrlage, SJ; Dasilva, E; Doench, JG; Donovan, KA; Duplaquet, L; Endress, JE; Fischer, ES; Gray, NS; Gygi, SP; Harris, IS; Ishoey, M; Kaelin, WG; Koduri, V; Lampson, BL; Liu, X; Medin, JA; Oser, MG; Ott, CJ; Paulk, J; Paulo, JA; Sabet, AH; Teng, M; Wang, AC; Zhang, T | 1 |
2 other study(ies) available for thalidomide and spautin-1
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Targeting oncoproteins with a positive selection assay for protein degraders.
Topics: Adaptor Proteins, Signal Transducing; Basic Helix-Loop-Helix Transcription Factors; Benzylamines; CRISPR-Cas Systems; Humans; Ikaros Transcription Factor; Oncogene Proteins; Proteolysis; Quinazolines; Thalidomide; Transcription Factors | 2021 |